Insulin says NO to cardiovascular disease

Cardiovascular Research

Volumn 89, Issue 3, 2011, Pages 516-524

  Yu, Qiujun ^a   Gao, Feng ^a   Ma, Xin L ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cardioprotection; Insulin; Insulin resistance; Myocardial ischaemia; Nitric oxide

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARDIOVASCULAR AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; GLUCOSE INSULIN POTASSIUM; INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PEROXYNITRITE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; AGING; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENZYME ACTIVITY; EXERCISE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANIMALS; DIABETIC ANGIOPATHIES; HUMANS; INSULIN; INSULIN RESISTANCE; MYOCARDIAL ISCHEMIA; NITRIC OXIDE;

EID: 79551492488     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq349     Document Type: Article

References (85)

1. Sodi-Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C et al. Effects of an intravenous infusion of a potassium-glucose- insulin solution on the elec-trocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1962;9:166-181.
2. Opie LH. The glucose hypothesis: relation to acute myocardial ischaemia. J Mol Cell Cardiol 1970;1:107-114.
3. Zhu P, Lu L, Xu Y, Greyson C, Schwartz GG. Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 2000;278:H595-H603.
4. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001;89:1191-1198.
5. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002;105:1497-1502.
6. Abel ED. Insulin signaling in heart muscle: lessons from genetically engineered mouse models. Curr Hypertens Rep 2004;6:416-423.
7. Lundberg JO, Gladwin MT, Ahluwalia A, Benjamin N, Bryan NS, Butler A et al. Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol 2009;5:865-869.
8. Das UN. Insulin: an endogenous cardioprotector. Curr Opin Crit Care 2003;9:375-383.
9. Schipke JD, Friebe R, Gams E. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials. Eur J Cardiothorac Surg 2006;29:479-485.
10. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004;114:1187-1195. (Pubitemid 40385286)
11. 2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem 2001;276:30392-30398.
12. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res 1999;43: 532-541.
13. Montagnani M, Ravichandran LV, Chen H, Esposito DL, Quon MJ. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol 2002;16: 1931-1942.
14. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H et al. Roles for insulin receptor, PI3-kinase, and Akt in signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;98:1539-1545.
15. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wort-mannin. Direct measurement in vascular endothelial cells. J Clin Invest 1996;98: 894-898.
16. Su H, Sun X, Ma H, Zhang HF, Yu QJ, Huang C et al. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab 2007;293:E629-E635.
17. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'Heuil D et al. Myo-cardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 1999;276:H1567-H1573.
18. Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, Mayer B. Attenuation of myo-cardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 2003;57:55-62.
19. Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2004;286:H276-H282.
20. Siegfried MR, Carey C, Ma XL, Lefer AM. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol 1992;263: H771-H777.
21. Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol 2001;37: 1335-1343.
22. Liu X, Huang Y, Pokreisz P, Marsboom G, Swinnen M, Verbeken E et al. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am Coll Cardiol 2007;50:808-817.
23. Heusch G, Post H, Michel MC, Kelm M, Schulz R. Endogenous nitric oxide and myo-cardial adaptation to ischemia. Circ Res 2000;87:146-152.
24. Li J, Wu F, Zhang H, Fu F, Ji L, Dong L et al. Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol 2009;47:512-519.
25. Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 2004;61:402-413.
26. Razavi HM, Hamilton JA, Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther 2005;106:147-162.
27. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999;84:253-256.
28. Kim YM, Kim TH, Seol DW, Talanian RV, Billiar TR. Nitric oxide suppression of apop-tosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J Biol Chem 1998;273:31437-31441.
29. Rossig L, Haendeler J, Hermann C, Malchow P, Urbich C, Zeiher AM et al. Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis. J Biol Chem 2000;275:25502-25507.
30. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 2001;104:253-256.
31. Ma H, Zhang HF, Yu L, Zang QJ, Li J, Huo JH et al. Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production. Cardiovasc Res 2006;69:57-65.
32. Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D et al. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 2002;106:466-472.
33. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004;109:849-854.
34. Li J, Zhang H, Wu F, Nan Y, Ma H, Guo W et al. Insulin inhibits tumor necrosis factor-α induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med 2008;36:1551-1558.
35. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation 2004;109 (21 Suppl 1):II27-II33.
36. Das UN. Is insulin an antiinflammatory molecule? Nutrition 2001;17:409-413.
37. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993;72:403-412.
38. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 2003;138:532-543.
39. Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M et al. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 1997;99:684-691.
40. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 2002;282:H1996-H2003.
41. Li D, Qu Y, Tao L, Liu H, Hu A, Gao F et al. Inhibition of iNOS protects the aging heart against b-adrenergic receptor stimulation-induced cardiac dysfunction and myo-cardial ischemic injury. J Surg Res 2006;131:64-72.
42. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997;94:6954-6958. (Pubitemid 27281972)
43. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 2000;85:2572-2575.
44. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E et al. Insulin inhibits intranuclear nuclear factor kB and stimulates IkB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001;86: 3257-3265.
45. Ji L, Fu F, Zhang L, Liu W, Cai X, Zhang L et al. Insulin attenuates myocardial ischemia/ reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab 2010;298:E871-E880.
46. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol 2004;24:1844-1854.
47. Duchen MR. Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signalling and cell death. J Physiol 1999;516:1-17.
48. Davidson SM, Hausenloy D, Duchen MR, Yellon DM. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 2006;38:414-419.
49. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003;299: 896-899.
50. Wolzt M, MacAllister RJ, Davis D, Feelisch M, Moncada S, Vallance P et al. Biochemical characterization of S-nitrosohemoglobin. Mechanisms underlying synthesis, NO release, and biological activity. J Biol Chem 1999;274:28983- 28990.
51. Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 1998;95:7631-7636.
52. Clementi E, Brown GC, Foxwell N, Moncada S. On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci USA 1999;96: 1559-1562.
53. Brookes PS, Zhang J, Dai L, Zhou F, Parks DA, Darley-Usmar VM et al. Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy. J Mol Cell Cardiol 2001;33:69-82.
54. Semenza GL. Perspectives on oxygen sensing. Cell 1999;98:281-284.
55. Abel ED. Myocardial insulin resistance and cardiac complications of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2005;5:219-226.
56. Botker HE, Moller N, Schmitz O, Bagger JP, Nielsen TT. Myocardial insulin resistance in patients with syndrome X. J Clin Invest 1997;100:1919-1927. (Pubitemid 27459344)
57. He Z, Opland DM, Way KJ, Ueki K, Bodyak N, Kang PM et al. Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol 2006;26:787-793.
58. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T et al. Hyper-glycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008;117:1610-1619.
59. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986;293:917-922.
60. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241.
61. Smit JWA, Romijn JA. Acute insulin resistance in myocardial ischemia: causes and consequences. Semin Cardiothorac Vasc Anesth 2006;10:215-219.
62. Yue Tl, Chen J, Bao W, Narayanan PK, Bril A, Jiang W et al. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-g agonist rosiglitazone. Circulation 2001;104:2588-2594.
63. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-g and PPAR-a) reduce myocardial infarct size. FASEB J 2002;16:1027-1040.
64. Huang PL. eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 2009;20:295-302.
65. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007;28:463-491.
66. Yu QJ, Si R, Zhou N, Zhang HF, Guo WY, Wang HC et al. Insulin inhibits b-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection. Apoptosis 2008;13:305-317.
67. Coats AJ, Anker S. Insulin resistance in chronic heart failure. J Cardiovasc Pharmacol 2000;35:S9-S14.
68. Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation 2004;109:951-957.
69. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165:677-682.
70. Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C et al. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 2007;293:H2009-H2023.
71. Shinozaki K, Ayajiki K, Nishio Y, Sugaya T, Kashiwagi A, Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 2004;43:255-262.
72. Zhang H, Li J, Li R, Zhang Q, Ma H, Ji Q et al. Reduced cardiotropic response to insulin in spontaneously hypertensive rats: role of peroxisome proliferator-activated receptor-g-initiated signaling. J Hypertens 2008;26:560-569.
73. Ma XL, Gao F, Nelson AH, Lopez BL, Christopher TA, Yue TL et al. Oxidative inac-tivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats. J Pharmacol Exp Ther 2001;298:879-885.
74. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopa-thy. Mol Cell Biochem 1998;180:53-57.
75. Zhang QJ, Li QX, Zhang HF, Zhang KR, Guo WY, Wang HC et al. Swim training sensitizes myocardial response to insulin: role of Akt-dependent eNOS activation. Cardiovasc Res 2007;75:369-380.
76. Li QX, Xiong ZY, Hu BP, Tian ZJ, Zhang HF, Guo WY et al. Aging-associated insulin resistance predisposes to hypertension and its reversal by exercise: the role of vascular vasorelaxation to insulin. Basic Res Cardiol 2009;104:269-284.
77. Hambrecht R, Adams V, Erbs S, Linke A, Kränkel N, Shu Y et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107:3152-3158.
78. Calvert JW, Lefer DJ. Myocardial protection by nitrite. Cardiovasc Res 2009;83: 195-203.
79. Calvert JW. Cardioprotective effects of nitrite during exercise. Cardiovasc Res 2011; 89:499-506.
80. Zhang KR, Liu HT, Zhang HF, Zhang QJ, Li QX, Yu QJ et al. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism. Apoptosis 2007;12:1579-1588.
81. Apstein CS. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. JAMA 2005;293:2596-2597.
82. Van den Berghe G. Insulin vs. strict blood glucose control to achieve a survival benefit after AMI? Eur Heart J 2005;26:639-641.
83. Goyal A, Mehta SR, D́az R, Gerstein HC, Afzal R, Xavier D et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation 2009;120:2429-2437.
84. Gao F, Yue TL, Shi DW, Christopher TA, Lopez BL, Ohlstein EH et al. P38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res 2002;53: 414-422.
85. Liu Z, Cao W. P38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets 2009;9:38-46.